Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Net Income (2016 - 2025)

Sangamo Therapeutics (SGMO) has disclosed Net Income for 16 consecutive years, with -$37.4 million as the latest value for Q4 2025.

  • For Q4 2025, Net Income fell 59.94% year-over-year to -$37.4 million; the TTM value through Dec 2025 reached -$122.9 million, down 25.52%, while the annual FY2025 figure was -$122.9 million, 25.52% down from the prior year.
  • Net Income hit -$37.4 million in Q4 2025 for Sangamo Therapeutics, down from -$34.9 million in the prior quarter.
  • Across five years, Net Income topped out at $21.1 million in Q1 2023 and bottomed at -$114.5 million in Q2 2023.
  • Average Net Income over 5 years is -$42.5 million, with a median of -$43.6 million recorded in 2022.
  • Year-over-year, Net Income crashed 3063.26% in 2021 and then surged 148.01% in 2023.
  • Sangamo Therapeutics' Net Income stood at -$37.5 million in 2021, then crashed by 38.71% to -$52.0 million in 2022, then dropped by 16.01% to -$60.3 million in 2023, then skyrocketed by 61.2% to -$23.4 million in 2024, then plummeted by 59.94% to -$37.4 million in 2025.
  • According to Business Quant data, Net Income over the past three periods came in at -$37.4 million, -$34.9 million, and -$20.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.